MINOXIDIL EXTRA STRENGTH (FOR MEN) Drug Patent Profile
✉ Email this page to a colleague
When do Minoxidil Extra Strength (for Men) patents expire, and when can generic versions of Minoxidil Extra Strength (for Men) launch?
Minoxidil Extra Strength (for Men) is a drug marketed by Apotex Inc, Aurobindo Pharma Ltd, Avacor Prods, P And L, Perrigo, and Perrigo New York. and is included in six NDAs.
The generic ingredient in MINOXIDIL EXTRA STRENGTH (FOR MEN) is minoxidil. There are eight drug master file entries for this compound. Ninety-five suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Minoxidil Extra Strength (for Men)
A generic version of MINOXIDIL EXTRA STRENGTH (FOR MEN) was approved as minoxidil by WATSON LABS on March 3rd, 1987.
Summary for MINOXIDIL EXTRA STRENGTH (FOR MEN)
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 27 |
Raw Ingredient (Bulk) Api Vendors: | 131 |
Clinical Trials: | 57 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MINOXIDIL EXTRA STRENGTH (FOR MEN) at DailyMed |
Recent Clinical Trials for MINOXIDIL EXTRA STRENGTH (FOR MEN)
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Industrial Farmacéutica Cantabria, S.A. | Phase 3 |
Bioskin GmbH | Phase 3 |
BioClever 2005 S.L. | Phase 3 |
Pharmacology for MINOXIDIL EXTRA STRENGTH (FOR MEN)
Drug Class | Arteriolar Vasodilator |
Physiological Effect | Arteriolar Vasodilation |